These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fuel for thought: immunometabolism is a paradigm shift in understanding immunity in cardiovascular disease. Caligiuri G; Norata GD Cardiovasc Res; 2019 Jul; 115(9):1383-1384. PubMed ID: 31199480 [No Abstract] [Full Text] [Related]
4. An update on the roles of immune system-derived microRNAs in cardiovascular diseases. Roberts LB; Kapoor P; Howard JK; Shah AM; Lord GM Cardiovasc Res; 2021 Nov; 117(12):2434-2449. PubMed ID: 33483751 [TBL] [Abstract][Full Text] [Related]
5. Something old, something new: a paradigm for considering immune therapies for cardiovascular disease. Weber BN; Blankstein R Cardiovasc Res; 2020 Apr; 116(5):e51-e53. PubMed ID: 32215658 [No Abstract] [Full Text] [Related]
6. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature. Herring MJ; Oskui PM; Hale SL; Kloner RA J Am Heart Assoc; 2013 Jul; 2(4):e000271. PubMed ID: 23842280 [No Abstract] [Full Text] [Related]
7. Immune and inflammatory mechanisms mediate cardiovascular diseases from head to toe. Libby P; Mallat Z; Weyand C Cardiovasc Res; 2021 Nov; 117(13):2503-2505. PubMed ID: 34698765 [No Abstract] [Full Text] [Related]
8. Macrophage Biology in Cardiovascular Diseases. Khoury MK; Yang H; Liu B Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):e77-e81. PubMed ID: 33054391 [TBL] [Abstract][Full Text] [Related]
9. The Innate Immune System and Cardiovascular Disease in ESKD: Monocytes and Natural Killer Cells. Dounousi E; Duni A; Naka KK; Vartholomatos G; Zoccali C Curr Vasc Pharmacol; 2021; 19(1):63-76. PubMed ID: 32600233 [TBL] [Abstract][Full Text] [Related]
10. Novel findings in neutrophil biology and their impact on cardiovascular disease. Bonaventura A; Montecucco F; Dallegri F; Carbone F; Lüscher TF; Camici GG; Liberale L Cardiovasc Res; 2019 Jul; 115(8):1266-1285. PubMed ID: 30918936 [TBL] [Abstract][Full Text] [Related]
11. The role of infiltrating immune cells in dysfunctional adipose tissue. Guzik TJ; Skiba DS; Touyz RM; Harrison DG Cardiovasc Res; 2017 Jul; 113(9):1009-1023. PubMed ID: 28838042 [TBL] [Abstract][Full Text] [Related]
12. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases. Liberale L; Ministrini S; Carbone F; Camici GG; Montecucco F Basic Res Cardiol; 2021 Mar; 116(1):23. PubMed ID: 33770265 [TBL] [Abstract][Full Text] [Related]
13. New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects. Davel AP; Jaffe IZ; Tostes RC; Jaisser F; Belin de Chantemèle EJ Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H989-H999. PubMed ID: 29957022 [TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of sphingosine-1-phosphate (S1P). Levkau B Handb Exp Pharmacol; 2013; (216):147-70. PubMed ID: 23563656 [TBL] [Abstract][Full Text] [Related]
15. Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives. Pedicino D; Giglio AF; Ruggio A; Massaro G; D'Aiello A; Trotta F; Lucci C; Graziani F; Biasucci LM; Crea F; Liuzzo G Thromb Haemost; 2018 Aug; 118(8):1352-1369. PubMed ID: 29991092 [TBL] [Abstract][Full Text] [Related]